Cargando…

Cell-Free DNA Methylation as Blood-Based Biomarkers for Pancreatic Adenocarcinoma—A Literature Update

Pancreatic adenocarcinoma has a horrible prognosis, which is partly due to difficulties in diagnosing the disease in an early stage. Additional blood-born biomarkers for pancreatic adenocarcinoma are needed. Epigenetic modifications, as changes in DNA methylation, is a fundamental part of carcinogen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henriksen, Stine Dam, Thorlacius-Ussing, Ole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8594668/ https://www.ncbi.nlm.nih.gov/pubmed/34968295 http://dx.doi.org/10.3390/epigenomes5020008

Ejemplares similares

Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinoma
por: Henriksen, Stine Dam, et al.
Publicado: (2017)

Cell-free DNA promoter hypermethylation in plasma as a diagnostic marker for pancreatic adenocarcinoma
por: Henriksen, Stine Dam, et al.
Publicado: (2016)

Promoter hypermethylation of SFRP1 as a prognostic and potentially predictive blood-based biomarker in patients with localized pancreatic ductal adenocarcinoma
por: Stubbe, Benjamin Emil, et al.
Publicado: (2023)

Validation of SFRP1 Promoter Hypermethylation in Plasma as a Prognostic Marker for Survival and Gemcitabine Effectiveness in Patients with Stage IV Pancreatic Adenocarcinoma
por: Stubbe, Benjamin Emil, et al.
Publicado: (2021)

High recovery of cell-free methylated DNA based on a rapid bisulfite-treatment protocol
por: Pedersen, Inge Søkilde, et al.
Publicado: (2012)

Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers
por: Ludvigsen, Maja, et al.
Publicado: (2021)

Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer
por: Ludvigsen, Maja, et al.
Publicado: (2020)

The prognostic efficacy of cell-free DNA hypermethylation in colorectal cancer
por: Rasmussen, Simon Ladefoged, et al.
Publicado: (2018)

Hypermethylated DNA, a circulating biomarker for colorectal cancer detection
por: Rasmussen, Simon Ladefoged, et al.
Publicado: (2017)

Preliminary investigation of elevated collagen and blood‐clotting markers as potential noninvasive biomarkers for small cell lung cancer
por: Thorlacius‐Ussing, Jeppe, et al.
Publicado: (2023)

MicroRNAs and Neutrophil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma
por: Oto, Julia, et al.
Publicado: (2020)

Usefulness of Imaging Response Assessment after Irreversible Electroporation of Localized Pancreatic Cancer—Results from a Prospective Cohort
por: Flak, Rasmus V., et al.
Publicado: (2021)

Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers’ Discovery
por: Brancaccio, Mariarita, et al.
Publicado: (2019)

Optimized cultivation of Campylobacter concisus from gut mucosal biopsies in inflammatory bowel disease
por: Kirk, Karina Frahm, et al.
Publicado: (2016)

Incidental detection of colorectal lesions on (18) F-FDG-PET/CT is associated with high proportion of malignancy: A study in 549 patients
por: Kousgaard, Sabrina Just, et al.
Publicado: (2020)

Complement activation capacity in plasma before and during high-dose prednisolone treatment and tapering in exacerbations of Crohn's disease and ulcerative colitis
por: Zimmermann-Nielsen, Erik, et al.
Publicado: (2005)

Diagnostic value of (18)F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA
por: Gade, Michael, et al.
Publicado: (2015)

Identification of DNA methylation-driven genes by integrative analysis of DNA methylation and transcriptome data in pancreatic adenocarcinoma
por: Zhang, Wei, et al.
Publicado: (2020)

A Diagnostic Panel of DNA Methylation Biomarkers for Lung Adenocarcinoma
por: Shen, Nan, et al.
Publicado: (2019)

An update on treatment options for pancreatic adenocarcinoma
por: Lambert, Aurélien, et al.
Publicado: (2019)

Whole Blood DNA Aberrant Methylation in Pancreatic Adenocarcinoma Shows Association with the Course of the Disease: A Pilot Study
por: Dauksa, Albertas, et al.
Publicado: (2012)

Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature
por: Galanopoulos, Michail, et al.
Publicado: (2017)

High serum levels of the C-propetide of type V collagen (PRO-C5) are prognostic for short overall survival in patients with pancreatic ductal adenocarcinoma
por: Nissen, Neel I., et al.
Publicado: (2023)

The Potential of Circulating Cell-Free DNA Methylation as an Epilepsy Biomarker
por: Martins-Ferreira, Ricardo, et al.
Publicado: (2022)

Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling
por: Endo, Yutaka, et al.
Publicado: (2021)

Is Cell-Free DNA Testing in Pancreatic Ductal Adenocarcinoma Ready for Prime Time?
por: Sheel, Ankur, et al.
Publicado: (2022)

Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibrogenesis
por: Pedersen, Rasmus S., et al.
Publicado: (2022)

Label-Free Quantitative Proteomics Unravels Carboxypeptidases as the Novel Biomarker in Pancreatic Ductal Adenocarcinoma
por: Song, Yang, et al.
Publicado: (2018)

Serum Type XIX Collagen is Significantly Elevated in Non-Small Cell Lung Cancer: A Preliminary Study on Biomarker Potential
por: Thorlacius-Ussing, Jeppe, et al.
Publicado: (2020)

The Microbiota Profile in Inflamed and Non-Inflamed Ileal Pouch–Anal Anastomosis
por: Kousgaard, Sabrina Just, et al.
Publicado: (2020)

Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients
por: de Vos, Luka, et al.
Publicado: (2017)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma
por: Zhang, Jie, et al.
Publicado: (2019)

Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA
por: Wu, Huanwen, et al.
Publicado: (2022)

Blood-based DNA Methylation Biomarkers for Early Detection of Colorectal Cancer
por: Dong, Lixn, et al.
Publicado: (2018)

Diagnostic biomarkers for pancreatic cancer: An update
por: Yang, Ming, et al.
Publicado: (2021)

Systemic treatment for inoperable pancreatic adenocarcinoma: review and update
por: Chan, Stephen L., et al.
Publicado: (2014)

Multidetector computer tomography in the pancreatic adenocarcinoma assessment: an update
por: Granata, Vincenza, et al.
Publicado: (2016)

Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma
por: Hong, Shubin, et al.
Publicado: (2023)

A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer
por: Shinjo, Keiko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bokaigj1rmjchqdg9mqrruag5d